Sen. Elizabeth Warren (D-Mass.) wants to make it easier for government-paid researchers to study marijuana – and not just its negative side effects.
Eight Democratic senators, led by Warren, are urging federal health and drug officials to address the “data shortfall” on potential health benefits of medical marijuana by making it easier for researchers to study the drug.
Cannabis and Cannabinoid Research, a new peer-reviewed, open access journal, will launch this fall as the world’s first journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids.
“Launching in fall 2015, the Journal will be the premier open source for authoritative cannabis and cannabinoid research, discussion, and debate” states a recent press release from Mary Ann Liebert, Inc., the publishing company behind the new journal, which will be published “under the Creative Commons Attribution 4.0 (CC BY) license to ensure broad dissemination and participation.”
A new study being published in the upcoming issue of the Journal of Neuroimmune Pharmacology, and e-published ahead of print by the National Institute of Health, has found that cannabis may have immunosuppressive and anti-inflammatory properties, which may help treat a variety of conditions such as autoimmune diseases and graft rejection.
According to researchers; “This review examines the effects of cannabinoids on immune function, with a focus on effects on T-cells, as well as on resistance to infection. The paper considers the immune modulating capacity of marijuana, of ∆9-THC extracted from the marijuana plant, and synthetic cannabinoids.”
Cannabinoids show “great promise” as a treatment option for nausea, according to a new study published in the journal Clinical Pharmacology & Therapeutics, and published online by the National Institute of Health.
“The sensation of nausea is one of the most debilitating human experiences”, according to the study’s researchers. “Current anti-emetic therapies are effective in reducing vomiting, but are less effective in reducing acute and delayed nausea and are completely ineffective in reducing anticipatory nausea.”
TEL AVIV, ISRAEL — Cannabis use is not associated with increased incidences of major depression, according to longitudinal data published online ahead of print in the Journal of Affective Disorders.
An international team of investigators from Israel and Canada assessed the association between cannabis use, major depressive disorder (MDD) and bipolar disorder (BP) in a three-year prospective study.
Authors determined that future incidence of MDD was not higher among cannabis users compared to nonusers. They reported: “Our results show no significant association between cannabis use and the incidence of major depression.
2014 has been an incredible year for the cannabis reform movement, with two more states, several cities and the District of Columbia voting in favor of legalization. In addition, it’s been an excellent year for cannabis science, with numerous studies being released that demonstrate its medical potential and diversity, and the benefits of its legalization. Below we breakdown what we believe to be the top 10 cannabis studies of 2014.
A study published by the Journal of the American Medical Association Internal Medicine in January found that states that have legalized medical cannabis have seen a drastic reduction in opioid overdose mortality rates. According to the study; “States with medical cannabis laws had a 24.8% lower mean annual opioid overdose mortality rate compared with states without medical cannabis laws.” Researchers note that the reduction was almost immediate, as every state that legalized medical cannabis saw a dramatic decrease in opioid overdose deaths within the first year (averaging about 20% less). The decline continued each year after. By the 5th year, states had experienced a decrease in opioid deaths ranging up to 50.9%.
The presence of tetrahydrocannabinol (THC) in the system is associated with increased survival rates in those who experience traumatic brain injury (TBI), according to a new study published in the American Journal of Surgery.
“Traumatic brain injury (TBI) is associated with significant morbidity and mortality”, says Dr. Binh Minh Nguyen, the study’s lead author. “Several studies have demonstrated neuroprotective effects of cannabinoids. The objective of this study was to establish a relationship between the presence of a positive toxicology screen for tetrahydrocannabinol (THC) and mortality after TBI.”
After examining 446 individuals – 18.4% of which had THC in their system – it was found that the mortality rate for the THC positive group was just 2.4% (two deaths total), compared with 11.5% (forty two deaths total) in the THC negative group; a 479% decrease.
The administration of cannabidiol (CBD), a nonpsychotropic cannabinoid, is associated with improved quality of life in patients with Parkinson’s disease, according clinical trial data published online ahead of print in the Journal of Psychopharmacology.
Investigators at the University of São Paulo in Brazil assessed the efficacy of CBD versus placebo in 21 subjects with Parkinson’s. Authors reported that the administration of 300 mg doses of CBD per day was associated with “significantly different mean total scores” in subjects’ well-being and quality of life compared to placebo.
New polling conducted by the Anzalone Liszt Grove Research group has found that 69% of Florida voters favor Amendment 2, an initiative to legalize medical cannabis which will be voted on November 4th. The poll found only 28% of voters in the state to be opposed to the initiative, which is a constitutional amendment, meaning it requires 60% of the vote to be passed into law.
“If you look at the poll numbers since the beginning of last year they are virtually unchanged, and they reassert what we’ve consistently said: Floridians overwhelmingly support medical marijuana,” said Ben Pollara, Campaign Manager for United for Care, the group behind Amendment 2. “Keeping medical decisions in the hands of doctors – not politicians – is simply not a controversial position for the vast majority of Floridians, and that has not changed over the last twenty-one months.”